NYSE:KND - Kindred Healthcare Stock Price, News, Headlines & Rumors

Sign in or create an account to add this stock to your watchlist.
$9.00 0.00 (0.00 %)
(As of 08/17/2018 04:00 PM ET)
Previous Close$9.00
Today's RangeN/A
52-Week Range$5.50 - $11.90
Average Volume815,663 shs
Market Capitalization$821.35 million
P/E Ratio26.47
Dividend YieldN/A
Kindred Healthcare logoKindred Healthcare, Inc. provides healthcare services in the United States. It operates through five segments: Home Health Services, Hospice Services, Hospitals, Kindred Hospital Rehabilitation Services, and RehabCare. The company provides long-term acute care (LTAC) services to post-intensive care and medically complex patients, including the critically ill and suffering from multiple organ system failures most commonly of the cardiovascular, pulmonary, kidney, gastro-intestinal, and cutaneous systems. It also offers home health, hospice, and community care services for patients in various settings comprising their homes, nursing centers, and other residential settings, as well as physician services for patients in home-based settings. In addition, the company operates inpatient rehabilitation hospitals (IRFs) and acute rehabilitation units (ARUs); and provides rehabilitation services, including physical and occupational therapies and speech pathology services to residents and patients of nursing centers, hospitals, outpatient clinics, home health agencies, and assisted living facilities. As of December 31, 2017, it operated 19 IRFs, 99 ARUs, 104 LTAC hospitals, 4 sub-acute units, and 123 outpatient clinics; provided rehabilitative services from 1,616 sites of service in 42 states; and offered Kindred at Home division home health, hospice, and community care services from 608 sites of service in 40 states. The company is headquartered in Louisville, Kentucky.

Receive KND News and Ratings via Email

Sign-up to receive the latest news and ratings for KND and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Nursing & personal care facilities
Sub-IndustryHealth Care Facilities


Debt-to-Equity Ratio10.04
Current Ratio1.73
Quick Ratio1.70


Trailing P/E Ratio26.47
Forward P/E Ratio14.06
P/E GrowthN/A

Sales & Book Value

Annual Sales$6.03 billion
Price / Sales0.14
Cash Flow$1.6216 per share
Price / Cash5.55
Book Value$3.80 per share
Price / Book2.37


EPS (Most Recent Fiscal Year)$0.34
Net Income$-698,350,000.00
Net Margins-11.56%
Return on Equity8.57%
Return on Assets0.70%


Outstanding Shares91,260,000
Market Cap$821.35 million

Kindred Healthcare (NYSE:KND) Frequently Asked Questions

What is Kindred Healthcare's stock symbol?

Kindred Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "KND."

How were Kindred Healthcare's earnings last quarter?

Kindred Healthcare, Inc. (NYSE:KND) posted its earnings results on Wednesday, February, 28th. The health services provider reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.02. The health services provider earned $1.48 billion during the quarter, compared to the consensus estimate of $1.48 billion. Kindred Healthcare had a negative net margin of 11.56% and a positive return on equity of 8.57%. The company's revenue was down 2.2% on a year-over-year basis. During the same quarter last year, the company earned $0.05 earnings per share. View Kindred Healthcare's Earnings History.

What price target have analysts set for KND?

5 brokerages have issued 1 year price objectives for Kindred Healthcare's stock. Their forecasts range from $6.50 to $9.00. On average, they anticipate Kindred Healthcare's share price to reach $8.00 in the next twelve months. This suggests that the stock has a possible downside of 11.1%. View Analyst Price Targets for Kindred Healthcare.

What is the consensus analysts' recommendation for Kindred Healthcare?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kindred Healthcare in the last year. There are currently 1 sell rating and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Kindred Healthcare.

Who are some of Kindred Healthcare's key competitors?

Who are Kindred Healthcare's key executives?

Kindred Healthcare's management team includes the folowing people:
  • Mr. Benjamin A. Breier, Pres, CEO & Director (Age 46)
  • Mr. Stephen D. Farber, Exec. VP & CFO (Age 48)
  • Mr. Kent H. Wallace, Exec. VP & COO (Age 63)
  • Mr. Stephen R. Cunanan, Chief Admin. Officer & Chief People Officer (Age 54)
  • Mr. David A. Causby, Exec. VP & Pres of Kindred at Home (Age 46)

Has Kindred Healthcare been receiving favorable news coverage?

Media coverage about KND stock has trended somewhat positive on Friday, according to Accern. The research group rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Kindred Healthcare earned a coverage optimism score of 0.03 on Accern's scale. They also assigned news stories about the health services provider an impact score of 45.47 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View Recent Headlines for Kindred Healthcare.

Who are Kindred Healthcare's major shareholders?

Kindred Healthcare's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.98%), Gardner Lewis Asset Management L P (5.49%), Water Island Capital LLC (3.94%), Gabelli Funds LLC (1.98%), Renaissance Technologies LLC (1.98%) and Schwab Charles Investment Management Inc. (1.72%). View Institutional Ownership Trends for Kindred Healthcare.

Which major investors are selling Kindred Healthcare stock?

KND stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Perella Weinberg Partners Capital Management LP, California Public Employees Retirement System, Rhumbline Advisers, KBC Group NV, Alps Advisors Inc., Alps Advisors Inc. and Bank of New York Mellon Corp. View Insider Buying and Selling for Kindred Healthcare.

Which major investors are buying Kindred Healthcare stock?

KND stock was purchased by a variety of institutional investors in the last quarter, including Gardner Lewis Asset Management L P, Renaissance Technologies LLC, BlackRock Inc., Millennium Management LLC, Gabelli Funds LLC, Water Island Capital LLC, Canada Pension Plan Investment Board and FNY Investment Advisers LLC. View Insider Buying and Selling for Kindred Healthcare.

How do I buy shares of Kindred Healthcare?

Shares of KND can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Kindred Healthcare's stock price today?

One share of KND stock can currently be purchased for approximately $9.00.

How big of a company is Kindred Healthcare?

Kindred Healthcare has a market capitalization of $821.35 million and generates $6.03 billion in revenue each year. The health services provider earns $-698,350,000.00 in net income (profit) each year or $0.34 on an earnings per share basis. Kindred Healthcare employs 85,300 workers across the globe.

How can I contact Kindred Healthcare?

Kindred Healthcare's mailing address is 680 South Fourth Street, Louisville KY, 40202. The health services provider can be reached via phone at 502-596-7300 or via email at [email protected]

MarketBeat Community Rating for Kindred Healthcare (NYSE KND)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  217 (Vote Outperform)
Underperform Votes:  299 (Vote Underperform)
Total Votes:  516
MarketBeat's community ratings are surveys of what our community members think about Kindred Healthcare and other stocks. Vote "Outperform" if you believe KND will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KND will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.